Insights

2 of the best ASX growth shares to buy for 2021 and beyond

Appen Ltd (ASX:APX) and this ASX growth share could be the ones to buy for strong returns in 2021 and beyond…
The post 2 of the best ASX growth shares to buy for 2021 and beyond appeared first on The Motley Fool Australia. –

A man drawing an arrow on a growth chart, indicating a surging share price

Looking to add a few growth shares to your portfolio next week? Then you might want to get better acquainted with the ones listed below.

The two shares listed below have been growing strongly and have been tipped to continue doing so in the future. Here’s what you need to know about them:

Appen Ltd (ASX: APX)

The first growth share to look at is Appen. It is the global leader in the development of high-quality, human annotated datasets for machine learning and artificial intelligence. Given the explosive growth of these markets, it has been growing at a strong rate over the last few years. While the pandemic is putting a dampener on things in FY 2021, management appears confident that demand will accelerate once the crisis passes and its strong form will resume.

According to a note out of Citi from last week, its analysts have a buy rating and $32.60 price target on the company’s shares. This compares to the latest Appen share price of $24.85. They believe recent share price weakness is a buying opportunity and remain very positive on its long term growth prospects.

ResMed Inc. (ASX: RMD)

Due to the growing demand for its industry-leading products in the fast-growing sleep treatment market, ResMed is another company which has been growing strongly in recent years. In fact, this strong form even continued in FY 2020 despite the pandemic. And with trading conditions improving, FY 2021 looks set to be another positive year of growth.

One broker that is very positive on the company’s future is Credit Suisse. Last month it upgraded the company’s shares to an outperform rating with a $31.00 price target. Its analysts believe ResMed is very well placed to benefit from a shift to home healthcare following the pandemic. Overall, it believes the company is capable of delivering double digit earnings growth for a number of years. The ResMed share price last traded at $28.25.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Appen Ltd. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 of the best ASX growth shares to buy for 2021 and beyond appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!